Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

207 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effects of the direct lipoprotein-associated phospholipase A(2) inhibitor darapladib on human coronary atherosclerotic plaque.
Serruys PW, García-García HM, Buszman P, Erne P, Verheye S, Aschermann M, Duckers H, Bleie O, Dudek D, Bøtker HE, von Birgelen C, D'Amico D, Hutchinson T, Zambanini A, Mastik F, van Es GA, van der Steen AF, Vince DG, Ganz P, Hamm CW, Wijns W, Zalewski A; Integrated Biomarker and Imaging Study-2 Investigators. Serruys PW, et al. Among authors: verheye s. Circulation. 2008 Sep 9;118(11):1172-82. doi: 10.1161/CIRCULATIONAHA.108.771899. Epub 2008 Sep 1. Circulation. 2008. PMID: 18765397 Clinical Trial.
The percutaneous assessment of regional and acute coronary hot unstable plaques by thermographic evaluation (PARACHUTE) study: a prospective reproducibility and prognostic clinical study using thermography to predict future ischemic cardiac events.
Verheye S, Van Langenhove G, van Es GA, Serruys P. Verheye S, et al. Int J Cardiovasc Intervent. 2004;6(2):69-75. doi: 10.1080/14628840410030397. Int J Cardiovasc Intervent. 2004. PMID: 15385205 Clinical Trial.
Angiographic, intravascular ultrasound, and fractional flow reserve evaluation of direct stenting vs. conventional stenting using BeStent2 in a multicentre randomized trial.
Wijns W, Verheye S, Manoharan G, Werner GS, Grube E, De Bruyne B, Koolen J, Hamm CW, Medina A, Bech JW, De Feyter PJ; CONVERTIBLE investigators. Wijns W, et al. Among authors: verheye s. Eur Heart J. 2005 Sep;26(18):1852-9. doi: 10.1093/eurheartj/ehi286. Epub 2005 May 11. Eur Heart J. 2005. PMID: 15888499 Clinical Trial.
The effect of variable dose and release kinetics on neointimal hyperplasia using a novel paclitaxel-eluting stent platform: the Paclitaxel In-Stent Controlled Elution Study (PISCES).
Serruys PW, Sianos G, Abizaid A, Aoki J, den Heijer P, Bonnier H, Smits P, McClean D, Verheye S, Belardi J, Condado J, Pieper M, Gambone L, Bressers M, Symons J, Sousa E, Litvack F. Serruys PW, et al. Among authors: verheye s. J Am Coll Cardiol. 2005 Jul 19;46(2):253-60. doi: 10.1016/j.jacc.2005.03.069. J Am Coll Cardiol. 2005. PMID: 16022951 Free article. Clinical Trial.
Quantification of coronary plaque by 64-slice computed tomography: a comparison with quantitative intracoronary ultrasound.
Otsuka M, Bruining N, Van Pelt NC, Mollet NR, Ligthart JM, Vourvouri E, Hamers R, De Jaegere P, Wijns W, Van Domburg RT, Stone GW, Veldhof S, Verheye S, Dudek D, Serruys PW, Krestin GP, De Feyter PJ. Otsuka M, et al. Among authors: verheye s. Invest Radiol. 2008 May;43(5):314-21. doi: 10.1097/RLI.0b013e31816a88a9. Invest Radiol. 2008. PMID: 18424952 Clinical Trial.
Quantitative ex vivo and in vivo comparison of lumen dimensions measured by optical coherence tomography and intravascular ultrasound in human coronary arteries.
Gonzalo N, Serruys PW, García-García HM, van Soest G, Okamura T, Ligthart J, Knaapen M, Verheye S, Bruining N, Regar E. Gonzalo N, et al. Among authors: verheye s. Rev Esp Cardiol. 2009 Jun;62(6):615-24. doi: 10.1016/s1885-5857(09)72225-x. Rev Esp Cardiol. 2009. PMID: 19480757 Free article. English, Spanish.
207 results